IOMEPROL

DRUG3 trials

Sponsors

Institut Jules Bordet, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Guerbet

Conditions

Breast cancerCoronary Artery Diseaseoropharyngal cancer

Phase 3

Patient reported outcomes in term of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced head and neck cancer patients treated with definitive chemo-radiotherapy

Active, not recruitingCTIS2023-506258-19-00

Institut Jules Bordetoropharyngal cancer

Start: 2019-12-11Target: 121Updated: 2025-10-06

Phase 4

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

CompletedNCT01255722

GuerbetCoronary Artery Disease

Start: 2010-11-30End: 2012-09-30Updated: 2015-12-16

Role of contrast enhanced mammography with Iomeprol 400 mgI/ml (Iomeron, Bracco), in the identification of breast cancer: I3-MaC Study

WithdrawnCTIS2024-513251-32-00

Azienda Ospedaliero-Universitaria Policlinico Umberto IBreast cancer

Target: 173Updated: 2024-07-09